Welcome to Iris Biotech
For better service please confirm your country and language we detected.
For better service please confirm your country and language we detected.
Thank you very much for your interest in our products. All prices listed on our website are ex-works, Germany, and may attract customs duties when imported.
You may/will be contacted by the shipping company for additional documentation that may be required by the US Customs for clearance.
We offer you the convenience of buying through a local partner, Peptide Solutions LLC who can import the shipment as well as prepay the customs duties and brokerage on your behalf and provide the convenience of a domestic sale.
Continue to Iris Biotech GmbHSend request to US distributorChemical name: (S)-N-alpha-(9-Fluorenylmethyloxycarbonyl)-N'-2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl-2-amino-4-guanidino-butyric acid // Synonyms: Fmoc-Agb(Pbf)-OH, Fmoc-Norarginine(Pbf)-OH, (S)-Fmoc-2-amino-5-(N'-Pbf-guanidino)-pentanoic acid,(S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-4-(3-((2,2,4,6,7-pentamethyl-2,3-dihydrobenzofuran- 5-yl)sulfonyl)guanidino)butanoic acid
from $206.25
Design, Synthesis, Molecular Dynamics Simulation, and Functional Evaluation of a Novel Series of 26RFa Peptide Analogues Containing a Mono- or Polyalkyl Guanidino Arginine Derivative; K. Alim, B. Lefranc, J. Sopkova-de Oliveira Santos, C. Dubessy, M. Picot, J. A. Boutin, H. Vaudry, N. Chartrel, D. Vaudry, J. Chuquet and J. Leprince; Journal of medicinal chemistry 2018; 61: 10185-10197. doi: https://doi.org/10.1021/acs.jmedchem.8b01332
Structure-Activity Relationship Study of Cyclic Pentapeptide Ligands for Atypical Chemokine Receptor 3 (ACKR3); H. Sekiguchi, T. Kuroyanagi, D. Rhainds, K. Kobayashi, Y. Kobayashi, H. Ohno, N. Heveker, K. Akaji, N. Fujii and S. Oishi; Journal of medicinal chemistry 2018; 61: 3745-3751. doi: https://doi.org/10.1021/acs.jmedchem.8b00336
Peptide Macrocycle Inhibitor of Coagulation Factor XII with Subnanomolar Affinity and High Target Selectivity; S. J. Middendorp, J. Wilbs, C. Quarroz, S. Calzavarini, A. Angelillo-Scherrer and C. Heinis; Journal of medicinal chemistry 2017; 60: 1151-1158. doi: https://doi.org/10.1021/acs.jmedchem.6b01548
A parallel semisynthetic approach for structure-activity relationship studies of peptide YY; L. Albertsen, S. Ostergaard, J. F. Paulsson, J. C. Norrild and K. Stromgaard; ChemMedChem 2013; 8: 1505-13, 1422. doi: https://doi.org/10.1002/cmdc.201300290
Trypsin resistance of a decapeptide KISS1R agonist containing an Nomega-methylarginine substitution; T. Asami, N. Nishizawa, Y. Ishibashi, K. Nishibori, Y. Horikoshi, H. Matsumoto, T. Ohtaki and C. Kitada; Bioorg Med Chem Lett 2012; 22: 6328-32. doi: https://doi.org/10.1016/j.bmcl.2012.08.087
Please send me more information about